Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation TCT 2022

Moving Beyond Pharmacotherapy: The Transformative Role of Devices in HF Treatment

Presenter: William Abraham

September 16, 2022

Presentation TCT 2017

Beyond Heparin: When and How to Escalate Therapy for Acute PE (Lytics, Catheter-Based, Surgery)

Presenter: Peter P. Monteleone, Thomas M. Tu, Jay S. Giri

November 01, 2017

Presentation TCT 2017

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Presenter: James E. Udelson

November 01, 2017

Presentation TCT 2017

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Presenter: Angeles Alonso Garcia

November 01, 2017

Presentation TCT 2016

Non-Pharmacological Treatment of Fluid Overload in ADHF Patients (WhiteSwell Medical)

Presenter: Emerson C. Perin, William T. Abraham

November 01, 2016

Presentation TCT 2016

Heart Failure Advances (Ivabradine, ARNI, and More)

Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy

October 30, 2016

Presentation TCT 2014

Postprocedural/Prehemostasis Intraarterial Nitroglycerin: A Prospective, Randomized Trial Evaluating Intrasheath Nitroglycerin to Improve Arterial Patency After Transradial Catheterization

Presenter: Steven R. Bailey, Surya Dharma

September 14, 2014

Presentation TCT 2012

REOPEN-AMI: A Prospective, Randomized Trial of Intracoronary Adenosine and Nitroprusside in Patients with ST-Segment Elevation Myocardial Infarction

Presenter: Niccoli Giampaolo

October 22, 2012

Advertisement

Moving Beyond Pharmacotherapy: The Transformative Role of Devices in HF Treatment

Beyond Heparin: When and How to Escalate Therapy for Acute PE (Lytics, Catheter-Based, Surgery)

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Non-Pharmacological Treatment of Fluid Overload in ADHF Patients (WhiteSwell Medical)

Heart Failure Advances (Ivabradine, ARNI, and More)

Postprocedural/Prehemostasis Intraarterial Nitroglycerin: A Prospective, Randomized Trial Evaluating Intrasheath Nitroglycerin to Improve Arterial Patency After Transradial Catheterization

REOPEN-AMI: A Prospective, Randomized Trial of Intracoronary Adenosine and Nitroprusside in Patients with ST-Segment Elevation Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content